Novel human α1a-adrenoceptor single nucleotide polymorphisms alter receptor pharmacology and biological function

Beilei Lei, Daniel P. Morris, Michael P. Smith, Laura P. Svetkey, Mark F. Newman, Jerome I. Rotter, Thomas A. Buchanan, Stephen M Beckstrom-Sternberg, Eric D. Green, Debra A. Schwinn

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

We identified nine naturally-occurring human single nucleotide polymorphisms (SNPs) in the α1a-adrenoceptor (α1aAR) coding region, seven of which result in amino acid change. Utilizing rat-1 fibroblasts stably expressing wild type α1aAR or each SNP at both high and low levels, we investigated the effect of these SNPs on receptor function. Compared with wild type, two SNPs (R166K, V311I) cause a decrease in binding affinity for agonists norepinephrine, epinephrine, and phenylephrine, and also shift the dose-response curve for norepinephrine stimulation of inositol phosphate (IP) production to the right (reduced potency) without altering maximal IP activity. In addition, SNP V311I and I200S display altered antagonist binding. Interestingly, a receptor with SNP G247R (located in the third intracellular loop) displays increased maximal receptor IP activity and stimulates cell growth. The increased receptor signaling for α1aAR G247R is not mediated by altered ligand binding or a deficiency in agonist-mediated desensitization, but appears to be related to enhanced receptor-G protein coupling. In conclusion, four naturally-occurring human α1aAR SNPs induce altered receptor pharmacology and/or biological activity. This finding has potentially important implications in many areas of medicine and can be used to guide α1aAR SNP choice for future clinical studies.

Original languageEnglish (US)
Pages (from-to)229-239
Number of pages11
JournalNaunyn-Schmiedeberg's Archives of Pharmacology
Volume371
Issue number3
DOIs
StatePublished - Mar 2005
Externally publishedYes

Fingerprint

Adrenergic Receptors
Single Nucleotide Polymorphism
Pharmacology
Inositol Phosphates
Norepinephrine
Phenylephrine
GTP-Binding Proteins
Epinephrine
Fibroblasts
Medicine
Ligands
Amino Acids
Growth

Keywords

  • α-Adrenoceptor
  • Human
  • Inositol phosphate
  • Polymorphism
  • Receptor/G protein coupling
  • Signal transduction
  • Single nucleotide polymorphisms

ASJC Scopus subject areas

  • Pharmacology

Cite this

Novel human α1a-adrenoceptor single nucleotide polymorphisms alter receptor pharmacology and biological function. / Lei, Beilei; Morris, Daniel P.; Smith, Michael P.; Svetkey, Laura P.; Newman, Mark F.; Rotter, Jerome I.; Buchanan, Thomas A.; Beckstrom-Sternberg, Stephen M; Green, Eric D.; Schwinn, Debra A.

In: Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 371, No. 3, 03.2005, p. 229-239.

Research output: Contribution to journalArticle

Lei, Beilei ; Morris, Daniel P. ; Smith, Michael P. ; Svetkey, Laura P. ; Newman, Mark F. ; Rotter, Jerome I. ; Buchanan, Thomas A. ; Beckstrom-Sternberg, Stephen M ; Green, Eric D. ; Schwinn, Debra A. / Novel human α1a-adrenoceptor single nucleotide polymorphisms alter receptor pharmacology and biological function. In: Naunyn-Schmiedeberg's Archives of Pharmacology. 2005 ; Vol. 371, No. 3. pp. 229-239.
@article{7f084dce608a4e1d8c8b5768d6942b61,
title = "Novel human α1a-adrenoceptor single nucleotide polymorphisms alter receptor pharmacology and biological function",
abstract = "We identified nine naturally-occurring human single nucleotide polymorphisms (SNPs) in the α1a-adrenoceptor (α1aAR) coding region, seven of which result in amino acid change. Utilizing rat-1 fibroblasts stably expressing wild type α1aAR or each SNP at both high and low levels, we investigated the effect of these SNPs on receptor function. Compared with wild type, two SNPs (R166K, V311I) cause a decrease in binding affinity for agonists norepinephrine, epinephrine, and phenylephrine, and also shift the dose-response curve for norepinephrine stimulation of inositol phosphate (IP) production to the right (reduced potency) without altering maximal IP activity. In addition, SNP V311I and I200S display altered antagonist binding. Interestingly, a receptor with SNP G247R (located in the third intracellular loop) displays increased maximal receptor IP activity and stimulates cell growth. The increased receptor signaling for α1aAR G247R is not mediated by altered ligand binding or a deficiency in agonist-mediated desensitization, but appears to be related to enhanced receptor-G protein coupling. In conclusion, four naturally-occurring human α1aAR SNPs induce altered receptor pharmacology and/or biological activity. This finding has potentially important implications in many areas of medicine and can be used to guide α1aAR SNP choice for future clinical studies.",
keywords = "α-Adrenoceptor, Human, Inositol phosphate, Polymorphism, Receptor/G protein coupling, Signal transduction, Single nucleotide polymorphisms",
author = "Beilei Lei and Morris, {Daniel P.} and Smith, {Michael P.} and Svetkey, {Laura P.} and Newman, {Mark F.} and Rotter, {Jerome I.} and Buchanan, {Thomas A.} and Beckstrom-Sternberg, {Stephen M} and Green, {Eric D.} and Schwinn, {Debra A.}",
year = "2005",
month = "3",
doi = "10.1007/s00210-005-1019-9",
language = "English (US)",
volume = "371",
pages = "229--239",
journal = "Naunyn-Schmiedeberg's Archives of Pharmacology",
issn = "0028-1298",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Novel human α1a-adrenoceptor single nucleotide polymorphisms alter receptor pharmacology and biological function

AU - Lei, Beilei

AU - Morris, Daniel P.

AU - Smith, Michael P.

AU - Svetkey, Laura P.

AU - Newman, Mark F.

AU - Rotter, Jerome I.

AU - Buchanan, Thomas A.

AU - Beckstrom-Sternberg, Stephen M

AU - Green, Eric D.

AU - Schwinn, Debra A.

PY - 2005/3

Y1 - 2005/3

N2 - We identified nine naturally-occurring human single nucleotide polymorphisms (SNPs) in the α1a-adrenoceptor (α1aAR) coding region, seven of which result in amino acid change. Utilizing rat-1 fibroblasts stably expressing wild type α1aAR or each SNP at both high and low levels, we investigated the effect of these SNPs on receptor function. Compared with wild type, two SNPs (R166K, V311I) cause a decrease in binding affinity for agonists norepinephrine, epinephrine, and phenylephrine, and also shift the dose-response curve for norepinephrine stimulation of inositol phosphate (IP) production to the right (reduced potency) without altering maximal IP activity. In addition, SNP V311I and I200S display altered antagonist binding. Interestingly, a receptor with SNP G247R (located in the third intracellular loop) displays increased maximal receptor IP activity and stimulates cell growth. The increased receptor signaling for α1aAR G247R is not mediated by altered ligand binding or a deficiency in agonist-mediated desensitization, but appears to be related to enhanced receptor-G protein coupling. In conclusion, four naturally-occurring human α1aAR SNPs induce altered receptor pharmacology and/or biological activity. This finding has potentially important implications in many areas of medicine and can be used to guide α1aAR SNP choice for future clinical studies.

AB - We identified nine naturally-occurring human single nucleotide polymorphisms (SNPs) in the α1a-adrenoceptor (α1aAR) coding region, seven of which result in amino acid change. Utilizing rat-1 fibroblasts stably expressing wild type α1aAR or each SNP at both high and low levels, we investigated the effect of these SNPs on receptor function. Compared with wild type, two SNPs (R166K, V311I) cause a decrease in binding affinity for agonists norepinephrine, epinephrine, and phenylephrine, and also shift the dose-response curve for norepinephrine stimulation of inositol phosphate (IP) production to the right (reduced potency) without altering maximal IP activity. In addition, SNP V311I and I200S display altered antagonist binding. Interestingly, a receptor with SNP G247R (located in the third intracellular loop) displays increased maximal receptor IP activity and stimulates cell growth. The increased receptor signaling for α1aAR G247R is not mediated by altered ligand binding or a deficiency in agonist-mediated desensitization, but appears to be related to enhanced receptor-G protein coupling. In conclusion, four naturally-occurring human α1aAR SNPs induce altered receptor pharmacology and/or biological activity. This finding has potentially important implications in many areas of medicine and can be used to guide α1aAR SNP choice for future clinical studies.

KW - α-Adrenoceptor

KW - Human

KW - Inositol phosphate

KW - Polymorphism

KW - Receptor/G protein coupling

KW - Signal transduction

KW - Single nucleotide polymorphisms

UR - http://www.scopus.com/inward/record.url?scp=20044377055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044377055&partnerID=8YFLogxK

U2 - 10.1007/s00210-005-1019-9

DO - 10.1007/s00210-005-1019-9

M3 - Article

VL - 371

SP - 229

EP - 239

JO - Naunyn-Schmiedeberg's Archives of Pharmacology

JF - Naunyn-Schmiedeberg's Archives of Pharmacology

SN - 0028-1298

IS - 3

ER -